What impact do prescription drug charges have on efficiency and equity? Evidence from high-income countries
- PMID: 18454849
- PMCID: PMC2412871
- DOI: 10.1186/1475-9276-7-12
What impact do prescription drug charges have on efficiency and equity? Evidence from high-income countries
Abstract
As pharmaceutical expenditure continues to rise, third-party payers in most high-income countries have increasingly shifted the burden of payment for prescription drugs to patients. A large body of literature has examined the relationship between prescription charges and outcomes such as expenditure, use, and health, but few reviews explicitly link cost sharing for prescription drugs to efficiency and equity. This article reviews 173 studies from 15 high-income countries and discusses their implications for important issues sometimes ignored in the literature; in particular, the extent to which prescription charges contain health care costs and enhance efficiency without lowering equity of access to care.
Similar articles
-
AMCP Guide to Pharmaceutical Payment Methods.J Manag Care Pharm. 2007 Oct;13(8 Suppl C):S1-39. J Manag Care Pharm. 2007. PMID: 17970611
-
The impact of user charges on the consumption of drugs. Empirical evidence and economic implications.Pharmacoeconomics. 1996 Jun;9(6):478-83. doi: 10.2165/00019053-199609060-00002. Pharmacoeconomics. 1996. PMID: 10160475
-
Impact of cost sharing on prescription drugs used by Medicare beneficiaries.Res Social Adm Pharm. 2010 Jun;6(2):100-9. doi: 10.1016/j.sapharm.2010.03.003. Epub 2010 May 7. Res Social Adm Pharm. 2010. PMID: 20511109
-
The High Cost of Prescription Drugs in the United States: Origins and Prospects for Reform.JAMA. 2016 Aug 23-30;316(8):858-71. doi: 10.1001/jama.2016.11237. JAMA. 2016. PMID: 27552619 Review.
-
[Risk sharing methods in middle income countries].Acta Pharm Hung. 2012;82(1):43-52. Acta Pharm Hung. 2012. PMID: 22570986 Review. Hungarian.
Cited by
-
Is 50 cent the price of the optimal copayment? - a qualitative study of patient opinions and attitudes in response to a 50 cent charge on prescription drugs in a publicly funded health system in Ireland.BMC Health Serv Res. 2013 Jan 10;13:16. doi: 10.1186/1472-6963-13-16. BMC Health Serv Res. 2013. PMID: 23305316 Free PMC article.
-
[Prescription drug consumption recovery following the co-payment change: Evidence from a regional health service].Aten Primaria. 2015 Aug-Sep;47(7):411-8. doi: 10.1016/j.aprim.2014.10.005. Epub 2014 Dec 11. Aten Primaria. 2015. PMID: 25500171 Free PMC article. Spanish.
-
Co-payments for general practitioners in Denmark: an analysis using two policy models.BMC Health Serv Res. 2017 Jan 5;17(1):9. doi: 10.1186/s12913-016-1951-z. BMC Health Serv Res. 2017. PMID: 28056968 Free PMC article. Review.
-
Inequalities in medicine use in Central Eastern Europe: an empirical investigation of socioeconomic determinants in eight countries.Int J Equity Health. 2015 Nov 5;14:124. doi: 10.1186/s12939-015-0261-0. Int J Equity Health. 2015. PMID: 26541292 Free PMC article.
-
Comparison of Canadian public medication insurance plans and the impact on out-of-pocket costs.CMAJ Open. 2017 Nov 22;5(4):E808-E813. doi: 10.9778/cmajo.20170065. CMAJ Open. 2017. PMID: 29180377 Free PMC article.
References
-
- Organisation for Economic Co-operation and Development . OECD Health Data 2005. Organisation for Economic Co-operation and Development; 2005. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials